摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-氯-1-甲基-5-(甲基硫烷基)-6-苯基-6H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮卓 | 153901-45-2

中文名称
8-氯-1-甲基-5-(甲基硫烷基)-6-苯基-6H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮卓
中文别名
——
英文名称
8-Chloro-1-methyl-5-methylsulfanyl-6-phenyl-6H-2,3,6,10b-tetraaza-benzo[e]azulene
英文别名
6H-(1,2,4)Triazolo(4,3-a)(1,5)benzodiazepine, 8-chloro-1-methyl-5-(methylthio)-6-phenyl-;8-chloro-1-methyl-5-methylsulfanyl-6-phenyl-[1,2,4]triazolo[4,3-a][1,5]benzodiazepine
8-氯-1-甲基-5-(甲基硫烷基)-6-苯基-6H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮卓化学式
CAS
153901-45-2
化学式
C18H15ClN4S
mdl
——
分子量
354.863
InChiKey
MPTRWTCLOASBBX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.5
  • 重原子数:
    24
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    59.2
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-甲基哌嗪8-氯-1-甲基-5-(甲基硫烷基)-6-苯基-6H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮卓 在 diphenyl ether-biphenyl eutectic 、 对甲苯磺酸 作用下, 反应 24.0h, 以52%的产率得到8-氯-1-甲基-5-(4-甲基哌嗪-1-基)-6-苯基-[1,2,4]三唑并[4,3-a][1,5]苯并二氮杂卓
    参考文献:
    名称:
    1,5-Benzodiazepines XI. 5-(Dialkylamino) or 5-(alkylthio) substituted 8-chloro-6-phenyl-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepines with anticonvulsant activity
    摘要:
    The cyclocondensation of (dimethylamino)benzodiazepinones 3a,b with hydrazides yielded triazolobenzodiazepinones 4 which were treated with Lawesson's reagent to give thiolactams 5. The phase-transfer catalyzed (TEBA) alkylation of compounds 5 with suitable alkyl halides afforded 5-(alkylthio)-6-phenyl-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepines 6a-f. The desired N,N-dialkyl-6-phenyl-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5-amines 7a-k were finally obtained from the reaction of the (methylthio)derivatives 6a-d with proper dialkylamines. Compounds 6b-f and 7a-e, g-k were screened for anticonvulsant activity after a preliminary evaluation of their gross behavioral effects and acute toxicity. Nine of the 15 triazolobenzodiazepines tested exerted a clear-cut anticonvulsant effect associated with low acute toxicity. In particular, the most active compounds 6e, f and 7h showed LD50/ED50 ratios that were notably higher than that of phenobarbital and ranging from 50% to 20% of that of diazepam, the latter used as reference drugs.
    DOI:
    10.1016/0223-5234(93)90088-v
  • 作为产物:
    参考文献:
    名称:
    1,5-Benzodiazepines XI. 5-(Dialkylamino) or 5-(alkylthio) substituted 8-chloro-6-phenyl-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepines with anticonvulsant activity
    摘要:
    The cyclocondensation of (dimethylamino)benzodiazepinones 3a,b with hydrazides yielded triazolobenzodiazepinones 4 which were treated with Lawesson's reagent to give thiolactams 5. The phase-transfer catalyzed (TEBA) alkylation of compounds 5 with suitable alkyl halides afforded 5-(alkylthio)-6-phenyl-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepines 6a-f. The desired N,N-dialkyl-6-phenyl-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5-amines 7a-k were finally obtained from the reaction of the (methylthio)derivatives 6a-d with proper dialkylamines. Compounds 6b-f and 7a-e, g-k were screened for anticonvulsant activity after a preliminary evaluation of their gross behavioral effects and acute toxicity. Nine of the 15 triazolobenzodiazepines tested exerted a clear-cut anticonvulsant effect associated with low acute toxicity. In particular, the most active compounds 6e, f and 7h showed LD50/ED50 ratios that were notably higher than that of phenobarbital and ranging from 50% to 20% of that of diazepam, the latter used as reference drugs.
    DOI:
    10.1016/0223-5234(93)90088-v
点击查看最新优质反应信息

文献信息

  • 1,5-Benzodiazepines XI. 5-(Dialkylamino) or 5-(alkylthio) substituted 8-chloro-6-phenyl-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepines with anticonvulsant activity
    作者:GC Grossi、M Di Braccio、G Roma、M Ghia、G Brambilla
    DOI:10.1016/0223-5234(93)90088-v
    日期:1993.1
    The cyclocondensation of (dimethylamino)benzodiazepinones 3a,b with hydrazides yielded triazolobenzodiazepinones 4 which were treated with Lawesson's reagent to give thiolactams 5. The phase-transfer catalyzed (TEBA) alkylation of compounds 5 with suitable alkyl halides afforded 5-(alkylthio)-6-phenyl-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepines 6a-f. The desired N,N-dialkyl-6-phenyl-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5-amines 7a-k were finally obtained from the reaction of the (methylthio)derivatives 6a-d with proper dialkylamines. Compounds 6b-f and 7a-e, g-k were screened for anticonvulsant activity after a preliminary evaluation of their gross behavioral effects and acute toxicity. Nine of the 15 triazolobenzodiazepines tested exerted a clear-cut anticonvulsant effect associated with low acute toxicity. In particular, the most active compounds 6e, f and 7h showed LD50/ED50 ratios that were notably higher than that of phenobarbital and ranging from 50% to 20% of that of diazepam, the latter used as reference drugs.
查看更多

同类化合物

叔-丁基3-(羟甲基)-7,8-二氢-4H-[1,2,3]三唑并[1,5-A][1,4]二氮杂卓-5(6H)-甲酸基酯 乙基4-(4H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮卓-5-基)哌嗪-1-羧酸酯 9H-[1,2,4]三唑并[4,3-a][1,4]二氮杂卓 9-氯-5,6-二氢-4-甲基-1-(2-噻吩基)-4H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮杂卓 9-氯-1-(2-呋喃基)-5,6-二氢-4-甲基-4H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮杂卓 8-氯-5-(4-甲基哌嗪-1-基)-6-苯基-[1,2,4]三唑并[4,3-a][1,5]苯并二氮杂卓 8-氯-1-甲基-5-(甲基硫烷基)-6-苯基-6H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮卓 2-[(8-氯-6-苯基-6H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮卓-5-基)硫烷基]-N,N-二甲基乙胺 2-[(8-氯-1-甲基-6-苯基-[1,2,4]三唑并[4,3-a][1,5]苯并二氮杂卓-5-基)硫基]-N,N-二甲基乙胺 1H-环丙并[d][1,2,4]三唑并[4,3-b]哒嗪 1H,5H-[1,2,4]三唑并[1,2-a][1,2]二氮杂卓-1,3,5(2H)-三酮,6,9-二氢-2,7-二甲基-9-(2-吡啶基)- (9ci)-1H-1,2,4-噻唑并[4,3-c][1,3]二氮杂卓 (9ci)-1H-1,2,4-噻唑并[4,3-a][1,4]二氮杂卓 ethyl 1,5-di(4-chlorophenyl)-4a-methyl-3a-phenyl-3a,4a,8,13-tetrahydro-4H-[1,2,4]oxadiazolo[5,4-d][1,2,4]triazolo[4,3-a][1,5]benzodiazepine-7-carboxylate ethyl 1-(4-chlorophenyl)-4a-methyl-5-(4-nitrophenyl)-3a-phenyl-3a,4a,8,13-tetrahydro-4H-[1,2,4]oxadiazolo[5,4-d][1,2,4]triazolo[4,3-a][1,5]benzodiazepine-7-carboxylate ethyl 3,7-di(4-chlorophenyl)-3a-methyl-4a,5-diphenyl-3a,4a,8,13-tetrahydro-4H-bis-[1,2,4-triazolo][4,3-a:3',4'-d][1,5]benzodiazepine-1-carboxylate ethyl 7-(4-chlorophenyl)-3a-methyl-3-(4-nitrophenyl)-4a,5-diphenyl-3a,4a,8,13-tetrahydro-4H-bis-[1,2,4-triazolo][4,3-a:3',4'-d][1,5]benzodiazepine-1-carboxylate 5,6-Dihydro-6-(4-nitrobenzoyl)-4H-[1,2,4]triazolo-[4,3-a][1,5]benzodiazepin 6,7-dibromo-9-[(diethylamino)acetyl]-3H-pyrido[3,2-c]-s-triazolo-[4,3-a][1,5]benzodiazepin-3-one 3-(trifluoromethyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a][1,3]diazepine 1-ethoxycarbonyl-3a-methyl-3-(4-tolyl)-5-phenyl-3,3a,4,11-tetrahydro-<1,2,4>triazolo<4,3-a><1,5> benzodiazepine aminomethyl-7,8-dihydro-4H-[1,2,3]triazolo[1,5-a][1,4]diazepine-5(6H)-carboxylic acid tert-butyl ester ethyl 3a-methyl-3-(4-nitrophenyl)-4a,5-diphenyl-7-(4-tolyl)-3a,4a,8,13-tetrahydro-4H-bis-[1,2,4-triazolo][4,3-a:3',4'-d][1,5]benzodiazepine-1-carboxylate diethyl trans-3a-methyl-4a-phenyl-3,5-bis(p-nitrophenyl)-3a,4,4a,5-tetrahydro-3H-bis<1,2,4>triazolo<4,3-a:3',4'-d><1,5>benzodiazepine-1,7-dicarboxylate diethyl cis-3a-methyl-4a-phenyl-3,5-bis(p-nitrophenyl)-3a,4,4a,5-tetrahydro-3H-bis<1,2,4>triazolo<4,3-a:3',4'-d><1,5>benzodiazepine-1,7-dicarboxylate ethyl 3-(4-chlorophenyl)-3a-methyl-4a,5-diphenyl-7-(4-tolyl)-3a,4a,8,13-tetrahydro-4H-bis-[1,2,4-triazolo][4,3-a:3',4'-d][1,5]benzodiazepine-1-carboxylate 1-ethoxycarbonyl-3a-methyl-3,5-diphenyl-3,3a,4,11-tetrahydro-<1,2,4>triazolo<4,3-a><1,5> benzodiazepine 4-hydro-5-phenyl-1H-s-triazolo<4,3-a><1,5>benzodiazepin-1-one 2,4-dihydro-5-phenyl-1H-s-triazolo<4,3-a><1,5>benzodiazepin-1-one 4-hydro-2-methyl-5-phenyl-1H-s-triazolo<4,3-a><1,5>benzodiazepin-1-one Dimethyl-1,7 ditriazolo<4,3-a;3,4-d>benzodiazepine-1,5 1-Methyl-5-piperidin-1-yl-4H-2,3,6,10b-tetraaza-benzo[e]azulene 1-Methyl-5-(4-methyl-piperazin-1-yl)-4H-2,3,6,10b-tetraaza-benzo[e]azulene 4-(1-Methyl-4H-2,3,6,10b-tetraaza-benzo[e]azulen-5-yl)-piperazine-1-carboxylic acid ethyl ester 8-Chloro-5-oxo-5,6-dihydro-4H-1,2,6,10b-tetraaza-benzo[e]azulene-3-carboxylic acid ethyl ester (1S,2R,8S,9R)-5-methyl-3,5,7-triazatetracyclo[7.2.1.02,8.03,7]dodec-10-ene-4,6-dione (1S,2S,8R,9R)-5-methyl-3,5,7-triazatetracyclo[7.2.1.02,8.03,7]dodec-10-ene-4,6-dione N,N-diethyl-4H-<1,2,4>triazolo<4,3-a><1,5>benzodiazepin-5-amine 9H-bis<1,2,4>triazolo<4,3-a:3',4'-d><1,5>benzodiazepine N,N-dimethyl-4H-<1,2,4>triazolo<4,3-a><1,5>benzodiazepin-5-amine 4H-<1,2,4>-triazolo<4,3-a><1,5>benzodiazepin-5(6H)-one 1-cyclohexyl-5,6-dihydro-4-(1H-indazol-3-ylmethyl)-5-oxo-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepine-6-acetic acid N,N-Dipropyl-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5-amine 1,4-Dimethyl-5,6-dihydro-4H-2,3,6,10b-tetraaza-benzo[e]azulene 2-methyl-hexahydro-6-oxa-2,3a,7c-triaza-4,4e-cyclo-cyclopenta[1,3]cyclopropa[1,2-a]cyclopropa[cd]-as-indacene-1,3-dione r-10a,t-11a-dimethyl-5,6,10,10a,11,11a-hexahydro-1,3,8,10-tetraphenyl-1H-bis<1,2,4>triazolo<4,3-d:3',4'-g><1,4>diazepine 4-(2-Dimethylaminoethyl)-1-methyl-8-chloro-6-phenyl-4H-s-triazolo[4,3-a] [1,5]benzodiazepin-5-one 3a,5,5-Trimethyl-1,3-diphenyl-3a,4,5,6-tetrahydro-3H-<1,2,4>triazolo<4,3-a><1,5>benzodiazepine (R)-8-bromo-1,4-dimethyl-5,6-dihydro-4H-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepine 9-chloro-4-methyl-1-naphthalen-2-yl-5,6-dihydro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine